Literature DB >> 2985879

Isoenzyme studies in human leukemia-lymphoma cell lines--1. Carboxylic esterase.

H G Drexler, G Gaedicke, J Minowada.   

Abstract

The isoenzyme patterns of carboxylic esterase (E.C. 3.1.1.1) were studied in 74 proven human leukemia-lymphoma and 12 normal B-lymphoblastoid cell lines. These cell lines have been extensively phenotyped using poly- and monoclonal antibodies. Esterase isoenzymes were separated by isoelectric focusing and visualized by histo-cytochemical techniques. No leukemia-specific or (except for monocytes) blood cell type-specific isoenzyme or isoenzyme pattern could be detected. The monocytic element in some cell lines was characterized by a strong isoenzyme band which could be selectively and completely inhibited by sodium fluoride. The enzyme phenotypes were stably expressed in all subcultures of a given cell line and did not appear to have any cell cycle dependency. The leukemia-lymphoma cell lines have been subclassified into four major groups according to immunological parameters: T-cell, B-cell, myelomonocytic and non-T, non-B-cell. On the basis of immunological data the T-cell lines were assigned to five stages of differentiation. The number and staining intensity of the isoenzymes increased with differentiation of the T-cells paralleling the expression of immunological markers. The B-cell leukemia-lymphoma cell lines were divided into pre B-, B-, Burkitt lymphoma, multiple myeloma and hairy cell leukemia cell lines. Substantial variability among the isoenzyme patterns was detected ranging from immature profiles of pre B-cell lines to complete isoenzyme repertoires of multiple myeloma cell lines. No significant difference was seen between the isoenzymes of mature B-cell lines and normal B-lymphoblastoid cell lines. The most prominent feature seen in myelomonocytic cell lines was the monocytic band indicating a monocytic origin and separating the 'monocytoid' from the 'pure myeloid' cell lines. Considerable heterogeneity in the isoenzyme patterns was observed in the non-T, non-B cell groups which comprised erythroleukemia cell lines and cell lines arrested at a very early stage of lymphoid differentiation. These latter cell lines together with some T- and B-cell lines shared the common characteristics of positivity for cALLA, TdT and Ia antigens and an immature, incomplete isoenzyme profile. The results support the notions of maturation arrest and normal gene expression in leukemic cell populations. Furthermore, the importance of biochemical studies as part of the multiple marker analysis could be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2985879     DOI: 10.1016/0145-2126(85)90084-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  Mutations in the human adenosine deaminase gene that affect protein structure and RNA splicing.

Authors:  A L Akeson; D A Wiginton; J C States; C M Perme; M R Dusing; J J Hutton
Journal:  Proc Natl Acad Sci U S A       Date:  1987-08       Impact factor: 11.205

2.  High concordance between marker profiles of 22 human leukemia-lymphoma cell lines tested with the same monoclonal antibodies before and during the second international workshop on human differentiation antigens.

Authors:  H G Drexler; S Gignac; B Misra; L Skowron; M Menon; J Minowada
Journal:  Cancer Immunol Immunother       Date:  1985       Impact factor: 6.968

3.  T-leukemia cell lines CCRF-CEM, HPB-ALL, JM and MOLT-4: changes in isoenzyme profiles during induction of differentiation.

Authors:  H G Drexler; G Gaedicke; J Minowada
Journal:  Blut       Date:  1987-02

4.  Phenotyping of malignant hematopoietic cells. Analysis of 1200 cases of leukemia-lymphoma.

Authors:  H G Drexler; M Menon; K Sagawa; E Tatsumi; H Koshiba; T Koishi; K Minato; T Sugimoto; M Saito; M Morita
Journal:  Blut       Date:  1986-02

5.  Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis.

Authors:  H G Drexler; M Menon; G Gaedicke; J Minowada
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

6.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

Authors:  R Amson; F Sigaux; S Przedborski; G Flandrin; D Givol; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

Review 7.  Options for imaging cellular therapeutics in vivo: a multi-stakeholder perspective.

Authors:  Brooke M Helfer; Vladimir Ponomarev; P Stephen Patrick; Philip J Blower; Alexandra Feitel; Gilbert O Fruhwirth; Shawna Jackman; Lucilia Pereira Mouriès; Margriet V D Z Park; Mangala Srinivas; Daniel J Stuckey; Mya S Thu; Tineke van den Hoorn; Carla A Herberts; William D Shingleton
Journal:  Cytotherapy       Date:  2021-04-06       Impact factor: 6.196

8.  Massive clonal expansion of polycytotoxic skin and blood CD8+ T cells in patients with toxic epidermal necrolysis.

Authors:  Axel Patrice Villani; Aurore Rozieres; Benoît Bensaid; Klara Kristin Eriksson; Amandine Mosnier; Floriane Albert; Virginie Mutez; Océane Brassard; Tugba Baysal; Mathilde Tardieu; Omran Allatif; Floriane Fusil; Thibault Andrieu; Denis Jullien; Valérie Dubois; Catherine Giannoli; Henri Gruffat; Marc Pallardy; François-Loïc Cosset; Audrey Nosbaum; Osami Kanagawa; Janet L Maryanski; Daniel Yerly; Jean-François Nicolas; Marc Vocanson
Journal:  Sci Adv       Date:  2021-03-19       Impact factor: 14.136

9.  Enhancer Hijacking Drives Oncogenic BCL11B Expression in Lineage-Ambiguous Stem Cell Leukemia.

Authors:  Lindsey E Montefiori; Sonja Bendig; Zhaohui Gu; Xiaolong Chen; Petri Pölönen; Xiaotu Ma; Alex Murison; Andy Zeng; Laura Garcia-Prat; Kirsten Dickerson; Ilaria Iacobucci; Sherif Abdelhamed; Ryan Hiltenbrand; Paul E Mead; Cyrus M Mehr; Beisi Xu; Zhongshan Cheng; Ti-Cheng Chang; Tamara Westover; Jing Ma; Anna Stengel; Shunsuke Kimura; Chunxu Qu; Marcus B Valentine; Marissa Rashkovan; Selina Luger; Mark R Litzow; Jacob M Rowe; Monique L den Boer; Victoria Wang; Jun Yin; Steven M Kornblau; Stephen P Hunger; Mignon L Loh; Ching-Hon Pui; Wenjian Yang; Kristine R Crews; Kathryn G Roberts; Jun J Yang; Mary V Relling; William E Evans; Wendy Stock; Elisabeth M Paietta; Adolfo A Ferrando; Jinghui Zhang; Wolfgang Kern; Torsten Haferlach; Gang Wu; John E Dick; Jeffery M Klco; Claudia Haferlach; Charles G Mullighan
Journal:  Cancer Discov       Date:  2021-06-08       Impact factor: 39.397

10.  Morphological and isoenzymatic differentiation of B-chronic lymphocytic leukaemia cells induced by phorbolester.

Authors:  H G Drexler; M Klein; N Bhoopalam; G Gaedicke; J Minowada
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.